- Home
- OABI vs MUE Comparison
OABI vs MUE Comparison
Compare OABI & MUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- MUE
- Stock Information
- Founded
- OABI 2012
- MUE 1999
- Country
- OABI United States
- MUE United States
- Employees
- OABI N/A
- MUE N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- MUE Investment Bankers/Brokers/Service
- Sector
- OABI Health Care
- MUE Finance
- Exchange
- OABI Nasdaq
- MUE Nasdaq
- Market Cap
- OABI 239.0M
- MUE 219.4M
- IPO Year
- OABI N/A
- MUE N/A
- Fundamental
- Price
- OABI $1.58
- MUE $10.07
- Analyst Decision
- OABI Strong Buy
- MUE
- Analyst Count
- OABI 3
- MUE 0
- Target Price
- OABI $6.67
- MUE N/A
- AVG Volume (30 Days)
- OABI 544.6K
- MUE 62.6K
- Earning Date
- OABI 11-04-2025
- MUE 01-01-0001
- Dividend Yield
- OABI N/A
- MUE 4.09%
- EPS Growth
- OABI N/A
- MUE N/A
- EPS
- OABI N/A
- MUE N/A
- Revenue
- OABI $21,094,000.00
- MUE N/A
- Revenue This Year
- OABI N/A
- MUE N/A
- Revenue Next Year
- OABI $48.89
- MUE N/A
- P/E Ratio
- OABI N/A
- MUE N/A
- Revenue Growth
- OABI 3.36
- MUE N/A
- 52 Week Low
- OABI $1.22
- MUE $8.53
- 52 Week High
- OABI $4.61
- MUE $10.17
- Technical
- Relative Strength Index (RSI)
- OABI 49.87
- MUE 53.38
- Support Level
- OABI $1.33
- MUE $10.01
- Resistance Level
- OABI $1.64
- MUE $10.13
- Average True Range (ATR)
- OABI 0.09
- MUE 0.08
- MACD
- OABI 0.01
- MUE -0.01
- Stochastic Oscillator
- OABI 55.92
- MUE 47.00
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About MUE Blackrock MuniHoldings Quality Fund II Inc.
BlackRock MuniHoldings Quality Fund II Inc is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. The fund seeks to achieve its investment objective by investing in long-term, investment-grade municipal obligations exempt from U.S. federal income taxes.